Gene amplification and increased expression of the reduced folate carrier in transport elevated K562 cells

Biochemical Pharmacology

Volumn 55, Issue 7, 1998, Pages 1135-1138

  Wong, So C ^a,b   Zhang, Long ^a   Proefke, Susan A ^a   Hukku, Bharati ^b,c   Matherly, Larry H ^a,b  

^a KARMANOS CANCER INSTITUTE   (United States)

^b WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c CHILDREN'S HOSPITAL OF MICHIGAN   (United States)

Author keywords

Folates; Gene amplification; Homogeneously staining region; Methotrexate; Transport

Indexed keywords

CARRIER PROTEIN; COMPLEMENTARY DNA; METHOTREXATE;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; DNA DETERMINATION; DRUG TRANSPORT; FLUORESCENCE IN SITU HYBRIDIZATION; FOLATE METABOLISM; GENE AMPLIFICATION; GENE EXPRESSION; NONHUMAN; PRIORITY JOURNAL; SOUTHERN BLOTTING;

BLOTTING, WESTERN; CARRIER PROTEINS; CELL LINE; CHROMOSOME ABERRATIONS; CHROMOSOMES, HUMAN, 21-22 AND Y; FOLIC ACID; GENE AMPLIFICATION; HUMANS; IN SITU HYBRIDIZATION; MEMBRANE PROTEINS; MEMBRANE TRANSPORT PROTEINS; TRANSLOCATION, GENETIC;

EID: 0032055906     PISSN: 00062952     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-2952(97)00639-4     Document Type: Article

References (20)

1. Goldman I.D., Matherly L.H. The cellular pharmacology of methotrexate. Pharmacol Ther. 28:1985;77-100.
2. Henderson G.B. Folate binding proteins. Annu Rev Nutr. 10:1990;319-335.
3. Sirotnak F.M. Obligate genetic expression in tumor cells of a fetal membrane property mediating "folate" transport Biological significance and implications for improved therapy of human cancer . Cancer Res. 45:1985;3992-4000.
4. Sirotnak F.M., Moccio D.M., Kelleher L.E., Goutas L.J. Relative frequency and kinetic properties of transport-defective phenotypes among methotrexate resistant L1210 clonal cell lines derived in vivo. Cancer Res. 41:1981;4447-4452.
5. Trippett T., Schlemmer S., Elisseyeff Y., Goker E., Wacher M., Steinherz P., Tan C., Berman E., Wright J.E., Rosowsky A., Schweitzer B., Bertino J.R. Defective transport as a mechanism of acquired resistance to methotrexate in patients with acute lymphocytic leukemia. Blood. 80:1992;1158-1162.
6. Fischer G.A. Defective transport of amethopterin (methotrexate) as a mechanism of resistance to the antimetabolite in L5178Y leukemic cells. Biochem Pharmacol. 11:1962;1233-1234.
7. Matherly L.H., Czajkowski C.A., Angeles S.M. Identification of a highly glycosylated methotrexate membrane carrier in K562 human erythroleukemia cells upregulated for tetrahydrofolate cofactor and methotrexate transport. Cancer Res. 51:1991;3420-3426.
8. Jansen G., Westerhof G.B., Jarmuszewski M.J.A., Kathmann I., Rijksen G., Schornagel J.H. Methotrexate transport in variant human CCRF-CEM leukemia cells with elevated levels of the reduced folate carrier Selective effect on carrier-mediated transport of physiological concentrations of reduced folates . J Biol Chem. 265:1990;18272-18277.
9. Sirotnak F.M., Moccio D.M., Yang C.H. A novel class of genetic variants of the L1210 cell up-regulated for folate analogue transport inward. J Biol Chem. 259:1984;13139-13144.
10. Fry D.W., Yalowich J.C., Goldman I.D. Rapid formation of polyglutamyl derivatives of methotrexate and their association with dihydrofolate reductase as assessed by high pressure liquid chromatography in the Ehrlich ascites tumor cells. J Biol Chem. 257:1982;1890-1896.
11. Matherly L.H., Angeles S.M., Czajkowski C.A. Characterization of transport-mediated methotrexate resistance in human tumor cells with antibodies to the membrane carrier for methotrexate and tetrahydrofolate cofactors. J Biol Chem. 267:1992;23253-23260.
12. Wong S.C., Proefke S.A., Bhushan A., Matherly L.H. Isolation of human cDNAs that restore methotrexate sensitivity and reduced folate carrier activity in methotrexate transport-defective Chinese hamster ovary cells. J Biol Chem. 270:1995;17468-17475.
13. Kraus J.P. Molecular analysis of cystathione β-synthase - a gene on chromosome 21. Prog Clin Biol Res. 360:1990;201-214.
14. Chomczynski P., Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem. 162:1987;156-159.
15. Peterson W.D. Jr, Simpson W.F., Hukku B. Cell culture characterization Monitoring for cell identification . Methods Enzymol. 58:1979;164-178.
16. Harlowe E and Lane D (Eds.), Protocols for immunoaffinity purification. In: Antibodies: a Laboratory Manual. Cold Spring Harbor Laboratory, Cold Spring Harbor, NY, 1988.
17. Laemmli U.K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature. 227:1970;680-685.
18. Moscow J.A., Gong M., He R., Sgagias M.K., Dixon K.H., Anzick S.L., Meltzer P.S., Cowan K.H. Isolation of a gene encoding a human reduced folate carrier (RFC1) and analysis of its expression in transport-deficient, methotrexate-resistant human breast cancer cells. Cancer Res. 55:1995;3790-3794.
19. Yang-Feng T.L., Ma Y.Y., Liang R., Prasad P.D., Leibach F.H., Ganapathy V. Assignment of the human folate transporter gene to chromosome 21q22.3 by somatic cell hybrid analysis and in situ hybridization. Biochem Biophys Res Commun. 210:1995;874-879.
20. Schimke R.T. Gene amplification in cultured cells. J Biol Chem. 263:1988;5989-5992.